Evidence map›Paper›PMID 30214615›Full record

ArticleOncology letters2018

Comparison of redox parameters in ovarian endometrioma and its malignant transformation.

Yoshikatsu Fujimoto, Shogo Imanaka, Yuki Yamada, Kenji Ogawa, Fuminori Ito, Naoki Kawahara, Chiharu Yoshimoto, Hiroshi Kobayashi

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Heme oxygenase 1: a novel oncogene in multiple gynecological cancers.International journal of biological sciences · 2021
    Review
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yoshikatsu FujimotoDepartment of Obstetrics and Gynecology, Japan Community Health Care Organization Yamato Koriyama, Yamato Koriyama, Nara 634-1013, Japan.
Shogo ImanakaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Yuki YamadaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Kenji OgawaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Fuminori ItoDepartment of Obstetrics and Gynecology, Nara Prefecture General Medical Center, Nara 631-0846, Japan.
Naoki KawaharaDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Chiharu YoshimotoDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Hiroshi KobayashiDepartment of Obstetrics and Gynecology, Nara Medical University, Kashihara, Nara 634-8522, Japan.
Nara Medical University · JPYamato Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aimed to evaluate the levels of oxidative stress and antioxidant markers in benign endometrioma (OE) and its malignant transformation [endometriosis-associated ovarian cancer (EAOC)] by measuring 8-hydroxy-2-deoxyguanosine (8-OHdG), heme oxygenase-1 (HO-1) and total antioxidant capacity (TAC/Heme-iron) alterations associated with disease progression. Cyst fluid samples from 44 patients with OE and 14 patients with EAOC were studied using an enzyme-linked immunosorbent assay. A χ

Indexed as

8-hydroxy-2-deoxyguanosineendometriosis-associated ovarian cancerheme oxygenase-1ovarian endometriomatotal antioxidant capacity

Identifiers

PMID30214615
PMCPMC6126218
OpenAlexW2887459775

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.